跳至主要内容
临床试验/ACTRN12611001002976
ACTRN12611001002976尚未招募3 期

In pre-diabetic adults aged 30-65 does zinc supplementation over 6 months compared with placebo improve glycemic control?

The University of Newcastle0 个研究点目标入组 40 人开始时间: 2011年9月20日最近更新:
适应症

试验速览

阶段
3 期
状态
尚未招募
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Blinded (masking used)

入排标准

年龄范围
30 Years 至 65 Years(—)
性别
All

入选标准

  • 1.30 to 65 yrs with BMI=23-27kg/m2 (overweight for South Asian Population) and;
  • 2.Oral glucose tolerance test (GTT) with results 8mmol/l to 11mmol/l at the beginning.
  • 3.Diagnosed as ‘prediabetic’ following a previous GTT within last 12 months.
  • 4.Resident of Dhaka city corporation and likely to live in the city during the study period.

排除标准

  • These include: known diabetes mellitus, pregnancy, renal insufficiency, cardiovascular disease, thyroid disease, liver disease or any other chronic disease, multiple co-morbidities, physical inactivity (wheelchair bound), psychiatric disorders, gastrointestinal disorders, pharmacology agents that may interfere with the intervention (for example, diuretics, and complementary medicines), morbid obesity. These will be determined from the results of the survey, clinical assessment and pathology testing.
  • These criteria are based on previous studies and are used to minimise confounding and drug interactions that may interfere with the intervention.

研究者

相似试验